Sajjala Bio to begin clinical trials on diabetes drug

In a statement, the Hyderabad-based company that reported Rs 15 crore of revenue last fiscal year, said it would soon take up clinical studies on the drug.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2JBtqB1
via IFTTT